rss
Thorax 2004;59:862-869 doi:10.1136/thx.2003.017244
  • Asthma

Airway inflammation in children with difficult asthma: relationships with airflow limitation and persistent symptoms

  1. D N R Payne1,
  2. Y Qiu2,
  3. J Zhu2,
  4. L Peachey2,
  5. M Scallan3,
  6. A Bush1,
  7. P K Jeffery2
  1. 1Department of Paediatrics, Imperial College London at the Royal Brompton Hospital, London SW3 6NP, UK
  2. 2Department of Gene Therapy, Imperial College London at the Royal Brompton Hospital, London SW3 6NP, UK
  3. 3Department of Anaesthetics, Imperial College London at the Royal Brompton Hospital, London SW3 6NP, UK
  1. Correspondence to:
    Professor P K Jeffery
    Lung Pathology, Royal Brompton Hospital, Sydney Street, London SW3 6NP, UK; p.jefferyimperial.ac.uk
  • Received 10 October 2003
  • Accepted 24 June 2004

Abstract

Background: The effective management and development of new treatments for children with difficult asthma requires investigation of the underlying airway pathology and its relationships with persistent symptoms and airflow limitation.

Methods: The density of immunologically distinct inflammatory cells and cells expressing interleukin (IL)-4, IL-5, and RANTES was determined in paraffin-embedded endobronchial biopsy specimens from 27 children with difficult asthma (6–16 years) following treatment with systemic corticosteroids. Eleven non-asthmatic children (7–16 years) acted as controls. Reticular basement membrane (RBM) thickness was also recorded and forced expiratory volume in 1 second (FEV1) and exhaled nitric oxide (FENO) measured, the latter in asthmatic children only.

Results: RBM thickness was greater in the asthmatic than the control group (median (range) 7.4 (3.1–11.1) v 5.1 (3.5–7.5) μm, p = 0.02). No other significant tissue difference was seen, nor was there a difference between asthmatic subjects with daily symptoms after systemic corticosteroids and those who became asymptomatic. CD4+ T lymphocyte density was higher in asthmatic subjects with persistent airflow limitation (post-bronchodilator FEV1<80% predicted) than in those without (9.1 (5.5–13.6) v 3.5 (0.6–34.9)%, p = 0.027). Analysing all asthmatic subjects together, there were negative correlations between CD4+ T lymphocytes and both pre-bronchodilator FEV1 (r  =  −0.57 (95% CI −0.79 to −0.23), p = 0.002) and post-bronchodilator FEV1 (r  =  −0.61 (95% CI −0.81 to −0.29), p<0.001). There were no significant correlations between FENO and inflammatory cells of any type.

Conclusion: In children with difficult asthma treated with systemic corticosteroids, persistent airflow limitation is associated with a greater density of CD4+ T lymphocytes in endobronchial biopsy specimens.

Footnotes

  • This study was funded by Asthma UK.

This Article

  1. Abstract
  2. Full text
  3. PDF

Register for free content


Free trial
Individuals may register for a free 30 day online trial to all content.

Free archive
The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.